Optical coherence tomography and multiple sclerosis: Update on clinical application and role in clinical trials

Jeffrey Lambe, Shiv Saidha, Robert A. Bermel

Research output: Contribution to journalReview article

Abstract

Optical coherence tomography (OCT) has emerged as a fast, non-invasive, inexpensive, high-resolution imaging technique in multiple sclerosis (MS). Retinal layer quantification by OCT facilitates a ‘window’ into not only local retinal pathology but also global neurodegenerative processes, recognised to be the principal substrates of disability accumulation in MS. While OCT measures in MS have been demonstrated to reflect visual function, inflammatory activity outside of the visual pathways, disability measures including the prediction of disability progression, whole brain atrophy, and the differential neuroprotective effects of disease-modifying therapies, debate continues regarding the clinical utility of OCT in everyday practice. This review presents an overview of the evidence supporting OCT, with particular focus on its application in the MS clinic. We will also discuss the role of OCT in MS clinical trials to develop novel neuroprotective and potential remyelinating therapies.

Original languageEnglish (US)
JournalMultiple Sclerosis Journal
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Optical Coherence Tomography
Multiple Sclerosis
Clinical Trials
Visual Pathways
Neuroprotective Agents
Atrophy
Pathology
Brain
Therapeutics

Keywords

  • clinical trials
  • clinical utility
  • Multiple sclerosis
  • optical coherence tomography

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Optical coherence tomography and multiple sclerosis : Update on clinical application and role in clinical trials. / Lambe, Jeffrey; Saidha, Shiv; Bermel, Robert A.

In: Multiple Sclerosis Journal, 01.01.2019.

Research output: Contribution to journalReview article

@article{84b472517e254f8d96737ba8cad0e6e7,
title = "Optical coherence tomography and multiple sclerosis: Update on clinical application and role in clinical trials",
abstract = "Optical coherence tomography (OCT) has emerged as a fast, non-invasive, inexpensive, high-resolution imaging technique in multiple sclerosis (MS). Retinal layer quantification by OCT facilitates a ‘window’ into not only local retinal pathology but also global neurodegenerative processes, recognised to be the principal substrates of disability accumulation in MS. While OCT measures in MS have been demonstrated to reflect visual function, inflammatory activity outside of the visual pathways, disability measures including the prediction of disability progression, whole brain atrophy, and the differential neuroprotective effects of disease-modifying therapies, debate continues regarding the clinical utility of OCT in everyday practice. This review presents an overview of the evidence supporting OCT, with particular focus on its application in the MS clinic. We will also discuss the role of OCT in MS clinical trials to develop novel neuroprotective and potential remyelinating therapies.",
keywords = "clinical trials, clinical utility, Multiple sclerosis, optical coherence tomography",
author = "Jeffrey Lambe and Shiv Saidha and Bermel, {Robert A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1352458519872751",
language = "English (US)",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Optical coherence tomography and multiple sclerosis

T2 - Update on clinical application and role in clinical trials

AU - Lambe, Jeffrey

AU - Saidha, Shiv

AU - Bermel, Robert A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Optical coherence tomography (OCT) has emerged as a fast, non-invasive, inexpensive, high-resolution imaging technique in multiple sclerosis (MS). Retinal layer quantification by OCT facilitates a ‘window’ into not only local retinal pathology but also global neurodegenerative processes, recognised to be the principal substrates of disability accumulation in MS. While OCT measures in MS have been demonstrated to reflect visual function, inflammatory activity outside of the visual pathways, disability measures including the prediction of disability progression, whole brain atrophy, and the differential neuroprotective effects of disease-modifying therapies, debate continues regarding the clinical utility of OCT in everyday practice. This review presents an overview of the evidence supporting OCT, with particular focus on its application in the MS clinic. We will also discuss the role of OCT in MS clinical trials to develop novel neuroprotective and potential remyelinating therapies.

AB - Optical coherence tomography (OCT) has emerged as a fast, non-invasive, inexpensive, high-resolution imaging technique in multiple sclerosis (MS). Retinal layer quantification by OCT facilitates a ‘window’ into not only local retinal pathology but also global neurodegenerative processes, recognised to be the principal substrates of disability accumulation in MS. While OCT measures in MS have been demonstrated to reflect visual function, inflammatory activity outside of the visual pathways, disability measures including the prediction of disability progression, whole brain atrophy, and the differential neuroprotective effects of disease-modifying therapies, debate continues regarding the clinical utility of OCT in everyday practice. This review presents an overview of the evidence supporting OCT, with particular focus on its application in the MS clinic. We will also discuss the role of OCT in MS clinical trials to develop novel neuroprotective and potential remyelinating therapies.

KW - clinical trials

KW - clinical utility

KW - Multiple sclerosis

KW - optical coherence tomography

UR - http://www.scopus.com/inward/record.url?scp=85073775171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073775171&partnerID=8YFLogxK

U2 - 10.1177/1352458519872751

DO - 10.1177/1352458519872751

M3 - Review article

AN - SCOPUS:85073775171

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

ER -